200 related articles for article (PubMed ID: 16473914)
1. Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.
Zhang L; Morikis D
Biophys J; 2006 May; 90(9):3106-19. PubMed ID: 16473914
[TBL] [Abstract][Full Text] [Related]
2. Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.
Kotwal GJ
Protein Cell; 2010 Dec; 1(12):1084-92. PubMed ID: 21213103
[TBL] [Abstract][Full Text] [Related]
3. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
Yadav VN; Pyaram K; Mullick J; Sahu A
J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095
[TBL] [Abstract][Full Text] [Related]
4. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.
Liszewski MK; Leung MK; Hauhart R; Buller RM; Bertram P; Wang X; Rosengard AM; Kotwal GJ; Atkinson JP
J Immunol; 2006 Mar; 176(6):3725-34. PubMed ID: 16517741
[TBL] [Abstract][Full Text] [Related]
5. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins.
Sfyroera G; Katragadda M; Morikis D; Isaacs SN; Lambris JD
J Immunol; 2005 Feb; 174(4):2143-51. PubMed ID: 15699145
[TBL] [Abstract][Full Text] [Related]
6. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
[TBL] [Abstract][Full Text] [Related]
7. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.
Rosengard AM; Liu Y; Nie Z; Jimenez R
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8808-13. PubMed ID: 12034872
[TBL] [Abstract][Full Text] [Related]
8. Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment.
Liszewski MK; Bertram P; Leung MK; Hauhart R; Zhang L; Atkinson JP
J Immunol; 2008 Sep; 181(6):4199-207. PubMed ID: 18768877
[TBL] [Abstract][Full Text] [Related]
9. Central modules of the vaccinia virus complement control protein are not in extensive contact.
Kirkitadze MD; Henderson C; Price NC; Kelly SM; Mullin NP; Parkinson J; Dryden DT; Barlow PN
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):167-75. PubMed ID: 10548547
[TBL] [Abstract][Full Text] [Related]
10. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.
Yadav VN; Pyaram K; Ahmad M; Sahu A
J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591
[TBL] [Abstract][Full Text] [Related]
11. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
12. Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity.
Liszewski MK; Leung MK; Hauhart R; Fang CJ; Bertram P; Atkinson JP
J Immunol; 2009 Sep; 183(5):3150-9. PubMed ID: 19667083
[TBL] [Abstract][Full Text] [Related]
13. NMR studies of a viral protein that mimics the regulators of complement activation.
Wiles AP; Shaw G; Bright J; Perczel A; Campbell ID; Barlow PN
J Mol Biol; 1997 Sep; 272(2):253-65. PubMed ID: 9299352
[TBL] [Abstract][Full Text] [Related]
14. Role of Electrostatic Hotspots in the Selectivity of Complement Control Proteins Toward Human and Bovine Complement Inhibition.
Narkhede YB; Gautam AK; Hsu RV; Rodriguez W; Zewde NT; Harrison RES; Arantes PR; Gaieb Z; Gorham RD; Kieslich C; Morikis D; Sahu A; Palermo G
Front Mol Biosci; 2021; 8():618068. PubMed ID: 33829039
[TBL] [Abstract][Full Text] [Related]
15. Immunophysical exploration of C3d-CR2(CCP1-2) interaction using molecular dynamics and electrostatics.
Zhang L; Mallik B; Morikis D
J Mol Biol; 2007 Jun; 369(2):567-83. PubMed ID: 17434528
[TBL] [Abstract][Full Text] [Related]
16. Variola virus immune evasion proteins.
Dunlop LR; Oehlberg KA; Reid JJ; Avci D; Rosengard AM
Microbes Infect; 2003 Sep; 5(11):1049-56. PubMed ID: 12941397
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia complement control protein: multi-functional protein and a potential wonder drug.
Jha P; Kotwal GJ
J Biosci; 2003 Apr; 28(3):265-71. PubMed ID: 12734405
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).
Rosengard AM; Alonso LC; Korb LC; Baldwin WM; Sanfilippo F; Turka LA; Ahearn JM
Mol Immunol; 1999 Jul; 36(10):685-97. PubMed ID: 10509819
[TBL] [Abstract][Full Text] [Related]
19. Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein.
Henderson CE; Bromek K; Mullin NP; Smith BO; Uhrín D; Barlow PN
J Mol Biol; 2001 Mar; 307(1):323-39. PubMed ID: 11243823
[TBL] [Abstract][Full Text] [Related]
20. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A
Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
